NASDAQ:LSTA
Lisata Therapeutics, Inc.
- Stock
Last Close
3.01
30/08 20:00
Market Cap
28.33M
Beta: 1.22
Volume Today
4.58K
Avg: 8.86K
PE Ratio
−1.29
PFCF: −1.02
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.19M - | 1.92M 61.01% | 2.74M 42.78% | 3.25M 18.53% | 4.29M 32.23% | 2.50M 41.72% | ||||||
average payables | 2.96M - | 4.51M 52.55% | 4.88M 8.35% | 4.24M 13.25% | 2.85M 32.62% | 1.05M 63.13% | 1.13M 6.98% | 1.25M 11.46% | 1.48M 17.69% | 2.29M 55.35% | 2.54M 10.61% | |
average receivables | 1.46M - | 2.49M 70.60% | 2.84M 14.18% | 2.73M 3.87% | 1.56M 42.72% | 117.23K 92.50% | 500K - | |||||
book value per share | 457.72 - | 267.96 41.46% | 73.33 72.63% | 11.19 84.74% | 84.47 655.05% | 58.41 30.86% | 30.24 48.22% | 31.57 4.39% | 25.01 20.76% | 12.85 48.62% | 5.96 53.60% | |
capex per share | -19.70 - | -16.75 14.97% | -9.85 41.18% | -6.53 33.75% | -0.23 96.53% | -0.21 8.31% | -0.02 - | -0.02 16.27% | -0.06 238.19% | |||
capex to depreciation | -1.68 - | -1.67 0.24% | -1.19 29.10% | -1.04 12.41% | -0.36 64.98% | -0.60 63.77% | -0.32 - | -1.09 243.64% | -4.13 278.62% | |||
capex to operating cash flow | 0.10 - | 0.08 21.47% | 0.08 4.05% | 0.12 48.36% | 0.01 94.62% | 0.01 3.46% | 0.00 - | 0.00 18.99% | 0.01 399.12% | |||
capex to revenue | -0.18 - | -0.20 11.11% | -0.14 30.51% | -0.08 43.00% | -0.00 - | |||||||
cash per share | 337.63 - | 120.23 64.39% | 62.83 47.74% | 33.68 46.39% | 92.12 173.47% | 66.65 27.64% | 36.55 45.17% | 33.59 8.10% | 25.75 23.33% | 13.36 48.10% | 6.26 53.16% | |
days of inventory on hand | 35.81 - | 59.76 66.88% | 52.72 11.78% | 41.99 20.35% | ||||||||
days payables outstanding | 94.58 - | 131.79 39.35% | 74.37 43.57% | 51.19 31.17% | 16.82 - | 4.68K 27,690.64% | ||||||
days sales outstanding | 46.30 - | 63.30 36.72% | 41.65 34.21% | 29.91 28.18% | ||||||||
debt to assets | 0.05 - | 0.13 185.31% | 0.29 122.51% | 0.13 55.32% | 0.00 98.08% | 0.01 - | 0.02 32.95% | 0.01 57.53% | 0.01 9.78% | 0.00 53.75% | ||
debt to equity | 0.07 - | 0.28 328.74% | 0.71 148.73% | 1.39 96.55% | 0.00 99.77% | 0.02 - | 0.02 12.91% | 0.01 59.70% | 0.01 5.88% | 0.00 52.10% | ||
dividend yield | ||||||||||||
earnings yield | -0.28 - | -0.44 59.34% | -1.54 247.46% | -1.76 14.14% | 0.69 139.29% | -0.47 167.69% | -0.78 65.48% | -0.37 52.46% | -0.59 60.30% | -4.14 600.03% | -0.95 77.15% | |
enterprise value | 97.80M - | 120.96M 23.69% | 48.85M 59.62% | 10.62M 78.26% | 4.18M 60.62% | 24.19M 478.62% | 12.24M 49.42% | 6.19M 49.41% | 22.54M 264.00% | -18.56M 182.37% | -248.71K 98.66% | |
enterprise value over ebitda | -2.66 - | -2.30 13.47% | -1.57 31.81% | -0.37 76.29% | -0.16 58.25% | -1.52 878.34% | -0.63 58.20% | -0.32 48.87% | -0.77 138.31% | 0.32 140.98% | 0.01 96.92% | |
ev to operating cash flow | -3.61 - | -2.58 28.52% | -1.24 51.76% | -0.45 63.94% | -0.20 55.35% | -1.21 504.39% | -0.65 46.46% | -0.70 8.27% | -1.01 44.37% | 0.88 186.56% | 0.01 98.58% | |
ev to sales | 6.67 - | 6.74 1.14% | 2.17 67.79% | 0.30 86.15% | -0.15 - | |||||||
free cash flow per share | -218.04 - | -231.50 6.17% | -131.25 43.30% | -60.74 53.72% | -35.14 42.15% | -31.15 11.36% | -27.43 11.93% | -8.59 68.68% | -6.05 29.60% | -4.14 31.52% | -2.48 40.09% | |
free cash flow yield | -0.21 - | -0.41 92.06% | -0.81 97.91% | -1.43 76.62% | -0.63 55.75% | -0.58 7.87% | -0.73 24.91% | -0.40 45.03% | -0.48 19.85% | -1.64 241.07% | -0.91 44.48% | |
graham net net | 149.12 - | -175.53 217.71% | -31.61 81.99% | -66.66 110.88% | 74.54 211.82% | 55.62 25.39% | 26.96 51.53% | 29.93 11.04% | 24.39 18.51% | 12.07 50.52% | 5.51 54.34% | |
graham number | 1.71K - | 1.23K 28.19% | 642.40 47.81% | 137.22 78.64% | 270.26 96.95% | 181.36 32.89% | 140.96 22.27% | 74.95 46.83% | 64.74 13.62% | 55.02 15.02% | 18.61 66.17% | |
income quality | 0.69 - | 0.85 23.18% | 0.48 42.68% | 0.71 46.62% | 1.29 81.68% | 1.24 4.24% | 0.98 21.07% | 1.08 11.08% | 0.81 25.27% | 0.39 51.80% | 0.96 146.21% | |
intangibles to total assets | 0.28 - | 0.58 107.09% | 0.17 70.00% | 0.18 4.00% | 0 100% | 0 | 0 | 0 | 0 | 0.00 Infinity% | 0.00 5.15% | |
interest coverage | -130.80 - | -76.41 41.58% | -53.49 29.99% | -16.87 68.46% | -73.04 333.02% | -3.40K 4,551.28% | 29.55 - | |||||
interest debt per share | 32.42 - | 79.67 145.72% | 58.46 26.63% | 19.81 66.11% | 0.90 95.47% | 0.01 99.14% | 0.51 6,543.89% | 0.61 17.88% | 0.19 68.06% | -0.28 245.98% | 0.02 107.36% | |
inventory turnover | 10.19 - | 6.11 40.08% | 6.92 13.35% | 8.69 25.54% | ||||||||
invested capital | 0.07 - | 0.28 328.74% | 0.71 148.73% | 1.39 96.55% | 0.00 99.77% | 0.02 - | 0.02 12.91% | 0.01 59.70% | 0.01 5.88% | 0.00 52.10% | ||
market cap | 139.78M - | 123.49M 11.65% | 52.39M 57.58% | 18.53M 64.63% | 33.19M 79.07% | 34.49M 3.94% | 25.92M 24.87% | 22.08M 14.80% | 46.47M 110.46% | 13.11M 71.80% | 22.04M 68.17% | |
net current asset value | 23.04M - | -31.92M 238.56% | -4.65M 85.44% | -23.12M 397.25% | 47.92M 307.31% | 36.98M 22.84% | 19.37M 47.61% | 31.57M 62.97% | 91.17M 188.79% | 65.17M 28.53% | 47.12M 27.69% | |
net debt to ebitda | 1.14 - | 0.05 95.78% | 0.11 136.33% | 0.28 143.68% | 1.08 288.55% | 0.65 39.96% | 0.71 9.75% | 0.83 17.41% | 0.82 1.38% | 0.54 34.17% | 0.87 61.57% | |
net income per share | -285.29 - | -251.28 11.92% | -250.12 0.46% | -74.81 70.09% | 38.43 151.37% | -25.03 165.13% | -29.20 16.67% | -7.91 72.92% | -7.45 5.84% | -10.47 40.56% | -2.58 75.34% | |
operating cash flow per share | -198.35 - | -214.75 8.27% | -121.40 43.47% | -54.22 55.34% | -34.91 35.60% | -30.94 11.38% | -27.43 11.34% | -8.57 68.75% | -6.03 29.63% | -4.09 32.24% | -2.48 39.28% | |
payables turnover | 3.86 - | 2.77 28.24% | 4.91 77.22% | 7.13 45.28% | 21.70 - | 0.08 99.64% | ||||||
receivables turnover | 7.88 - | 5.77 26.86% | 8.76 51.99% | 12.20 39.24% | ||||||||
research and ddevelopement to revenue | 1.15 - | 1.63 41.11% | 1.06 34.70% | 0.43 59.71% | 0.36 - | |||||||
return on tangible assets | -0.60 - | -1.03 70.54% | -1.71 66.70% | -0.77 55.07% | 0.36 147.20% | -0.36 200.02% | -0.74 104.13% | -0.23 69.45% | -0.28 25.21% | -0.75 163.44% | -0.38 48.67% | |
revenue per share | 107.35 - | 82.15 23.48% | 69.54 15.35% | 80.82 16.23% | 23.43 - | |||||||
roe | -0.62 - | -0.94 50.46% | -3.41 263.73% | -6.69 96.03% | 0.45 106.80% | -0.43 194.19% | -0.97 125.34% | -0.25 74.06% | -0.30 18.84% | -0.81 173.56% | -0.43 46.86% | |
roic | -0.56 - | -0.77 36.19% | -2.32 202.33% | -2.70 16.26% | -0.32 88.20% | -0.45 41.61% | -0.97 115.35% | -0.24 74.95% | -0.29 21.00% | -0.82 177.41% | -0.48 41.48% | |
sales general and administrative to revenue | 0.12 - | |||||||||||
shareholders equity per share | 457.72 - | 267.96 41.46% | 73.33 72.63% | 11.19 84.74% | 84.47 655.05% | 58.41 30.86% | 30.24 48.22% | 31.57 4.39% | 25.01 20.76% | 12.85 48.62% | 5.96 53.60% | |
stock based compensation to revenue | 0.47 - | 0.00 99.74% | 2.77 227,340.98% | 0.07 97.34% | 0.02 - | |||||||
tangible asset value | 37.03M - | -14.70M 139.68% | 13.39M 191.13% | -5.25M 139.24% | 50.19M 1,055.13% | 37.45M 25.38% | 20.55M 45.12% | 32.24M 56.87% | 92M 185.34% | 65.99M 28.27% | 47.63M 27.82% | |
tangible book value per share | 271.03 - | -67.30 124.83% | 41.41 161.54% | -12.04 129.07% | 83.94 797.34% | 57.98 30.92% | 29.86 48.50% | 31.32 4.90% | 24.95 20.36% | 12.74 48.93% | 5.90 53.69% | |
working capital | 41.02M - | 20.04M 51.15% | 8.26M 58.79% | 5.15M 37.66% | 51.80M 906.21% | 38.49M 25.70% | 20.00M 48.04% | 31.82M 59.16% | 91.66M 188.01% | 65.49M 28.55% | 47.33M 27.73% |
All numbers in USD (except ratios and percentages)